PCT (PCTL) Cash, Cash Equivalents, Marketable Securities : $0.03 Mil (As of Sep. 2022)

View and export this data going back to . Start your Free Trial

What is PCT Cash, Cash Equivalents, Marketable Securities?

PCT's quarterly cash, cash equivalents, marketable securities increased from Mar. 2022 ($0.00 Mil) to Jun. 2022 ($0.00 Mil) and increased from Jun. 2022 ($0.00 Mil) to Sep. 2022 ($0.03 Mil).

PCT's annual cash, cash equivalents, marketable securities increased from Dec. 2019 ($0.07 Mil) to Dec. 2020 ($0.12 Mil) and increased from Dec. 2020 ($0.12 Mil) to Dec. 2021 ($0.12 Mil).

PCT Cash, Cash Equivalents, Marketable Securities Historical Data

The historical data trend for PCT's Cash, Cash Equivalents, Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PCT Cash, Cash Equivalents, Marketable Securities Chart

PCT Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Cash, Cash Equivalents, Marketable Securities

Get a 7-Day Free Trial

0.01

0.07

0.12

PCT Quarterly Data
	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
Cash, Cash Equivalents, Marketable Securities	Get a 7-Day Free Trial															0.24	0.12	-	-	0.03

PCT Cash, Cash Equivalents, Marketable Securities Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

PCT (OTCPK:PCTL) Cash, Cash Equivalents, Marketable Securities Explanation

Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

PCT Cash, Cash Equivalents, Marketable Securities Related Terms

Thank you for viewing the detailed overview of PCT's Cash, Cash Equivalents, Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

PCT (PCTL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » PCT Ltd (OTCPK:PCTL) » Definitions » Cash, Cash Equivalents, Marketable Securities

Comparable Companies

Traded in Other Exchanges

N/A

Address

4235 Commerce Street, Little River, SC, USA, 29566

Website

https://www.pctl.com

PCT Ltd is a technology licensing company specializing in environmentally safe solutions for global sustainability. The company provides innovative products and technologies for eliminating contamination from water supplies, industrial fluids, hard surfaces, food processing equipment, and medical devices. The company markets new products and technologies for the Healthcare, Agriculture, and Oil & Gas industries. It designs, develops, integrates, assembles and commercializes technologies, products and systems targeted at the prevention and treatment of infectious disease and crop infestation. Its products include The Annihilyzer System, Large Volume Systems, Small Volume Systems, The Survivalyte System, and others.

Executives

Jody Read Francis	director, officer: Chief Operating Officer	9600 SW 67TH PATH, LAKE BUTLER FL 32054
Paul Branagan	director
William E Prince	director
Gary Grieco	director, 10 percent owner, officer: President	10457 W. 84TH TERRACE, LENEXA KS 66214
Gregory W Albers	director, officer: Secretary/Treasurer	10457 W. 84TH TERRACE, LENEXA KS 66214
John W Peters	director, officer: Secretary/Treasurer	2157 S LINCOLN STREET, SALT LAKE CITY UT 84106